Early experiences with edoxaban for stroke prevention in atrial fibrillation in the Southeast Asia region

Edoxaban, a once-daily, direct-acting oral anticoagulant, is approved to prevent stroke or systemic embolism in non-valvular atrial fibrillation (NVAF) and treat venous thromboembolism. The clinical benefit of edoxaban for stroke prevention in Asian patients with NVAF has been demonstrated in clinic...

Descripció completa

Dades bibliogràfiques

Autors principals:	Alejandro Bimbo Diaz, Jeremy Chow, Fan Kee Hoo, Kok Wei Koh, Gary Chin Keong Lee, Wee Siong Teo, Narayanaswamy Venketasubramanian, Chun-Chieh Wang, Radhika Mehta
Format:	Artigo
Idioma:	Inglês
Publicat:	BioExcel Publishing Ltd 2023-09-01
Col·lecció:	Drugs in Context
Matèries:	atrial fibrillation edoxaban southeast asia stroke
Accés en línia:	https://www.drugsincontext.com/early-experiences-with-edoxaban-for-stroke-prevention-in-atrial-fibrillation-in-the-southeast-asia-region/
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!